Green Health & Wellness Eli Lilly could launch obesity drug in India next year – GWC Mag gwcmagMarch 6, 2024035 views Health 28 February 2024, 12:55 pm 1 minute Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review. Market Impact The market opportunity is huge in the world’s most populous country, which has high obesity rates, especially among women, and the second-highest number of people with type-2 diabetes globally. Article Tags Topics of Interest: Health Type: Reuters Best Sectors: Pharmaceuticals & Healthcare Regions: Asia Countries: India Win Types: Exclusivity Story Types: Exclusive / Scoop Media Types: Text Customer Impact: Significant National Story